Literature DB >> 6747867

Pre-and post-junctional effects of tubocurarine and other nicotinic antagonists during repetitive stimulation in the rat.

A J Gibb, I G Marshall.   

Abstract

The effects of tubocurarine and trimetaphan have been examined at voltage-clamped rat diaphragm neuromuscular junctions during (a) single and repetitive stimulation of the phrenic nerve in cut muscles and (b) repetitive ionophoretic application of acetylcholine (ACh). Tubocurarine (2.5 X 10(-7)-10(-6)M) produced a concentration-dependent reduction in the amplitude of neurally evoked end-plate currents (e.p.c.s). It also reduced their time constant of decay (tau e.p.c.) in a manner that was independent of membrane potential, and not markedly dependent on the tubocurarine concentration. Likewise the snake alpha-neurotoxin, erabutoxin b, reduced the e.p.c. amplitude and produced a voltage-independent shortening of tau e.p.c. Estimates of mean channel lifetime (tau noise) from ACh-induced e.p.c. fluctuations revealed that (a) tau noise was 46.4 +/- 3.7% shorter than tau e.p.c. measured at the same end-plate. At these same end-plates in the presence of tubocurarine (2.5 X 10(-7)M) tau e.p.c. was 32.6 +/- 1.0% shorter than the control tau e.p.c. but tubocurarine did not change tau noise, (b) trimetaphan (2.5 X 10(-5)-2 X 10(-4)M) produced a concentration-dependent and voltage-dependent reduction of tau e.p.c., and a concentration-dependent reduction of peak e.p.c. amplitude. Trimetaphan (2.5 X 10(-5)M) produced a 50% reduction of tau noise. (a) Both tubocurarine and trimetaphan produced concentration-dependent increases in the run-down of trains of neurally evoked e.p.c.s (50 Hz, 0.4 s). This effect did not vary with membrane potential in tubocurarine, but was voltage dependent when induced by trimetaphan. (b) Erabutoxin b reduced the e.p.c. amplitude but did not produce any increase in the run-down of trains of neurally evoked e.p.c.s. During 50 Hz repetitive ionophoretic application of ACh, tubocurarine (2.5 X 10(-7)M) reduced the amplitude of each current in the train without inducing any run-down of the current amplitudes. This effect was not dependent on the membrane potential. In contrast trimetaphan (2.5 X 10(-5)M) induced a voltage-dependent run-down of trains of ionophoretically evoked e.p.c.s. We conclude that tubocurarine and erabutoxin b reduce the e.p.c. amplitude by blocking the post-junctional ACh receptor. Tubocurarine produces tetanic rundown of e.p.c.s. by a prejunctional mechanism, whereas the effects of trimetaphan during single and repetitive stimulation are at least partly due to block of the open ion channel associated with the ACh receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6747867      PMCID: PMC1193117          DOI: 10.1113/jphysiol.1984.sp015245

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  51 in total

1.  ANTIDROMIC ACTIVITY IN THE RAT PHRENIC NERVE-DIAPHRAGM PREPARATION.

Authors:  M RANDIC; D W STRAUGHAN
Journal:  J Physiol       Date:  1964-09       Impact factor: 5.182

2.  Reduction of transmitter release by D-tubocurarine.

Authors:  J I Hubbard; D F Wilson; M Miyamoto
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

3.  Transversaly cut diaphragm preparation from rat. An adjuvant tool in the study of the physiology and pbarmacology of the myoneural junction.

Authors:  J A Barstad; G Lilleheil
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-10

4.  Voltage jump analysis of procaine action at frog end-plate.

Authors:  P R Adams
Journal:  J Physiol       Date:  1977-06       Impact factor: 5.182

Review 5.  Acetylcholine receptor kinetics.

Authors:  P R Adams
Journal:  J Membr Biol       Date:  1981-02-28       Impact factor: 1.843

6.  Drug-receptor interaction at the frog neuromuscular junction.

Authors:  F Dreyer; K Peper; R Sterz; R J Bradley; K D Müller
Journal:  Prog Brain Res       Date:  1979       Impact factor: 2.453

7.  An analysis of the action of a false transmitter at the neuromuscular junction.

Authors:  D Colquhoun; W A Large; H P Rang
Journal:  J Physiol       Date:  1977-04       Impact factor: 5.182

8.  Absence of [125I] alpha-bungarotoxin binding to motor nerve terminals of frog, lizard and mouse muscle.

Authors:  S W Jones; M M Salpeter
Journal:  J Neurosci       Date:  1983-02       Impact factor: 6.167

9.  Interactions of d-tubocurarine with the nicotinic acetylcholine receptor/channel molecule.

Authors:  N Shaker; A T Eldefrawi; L G Aguayo; J E Warnick; E X Albuquerque; M E Eldefrawi
Journal:  J Pharmacol Exp Ther       Date:  1982-01       Impact factor: 4.030

10.  Voltage clamp analysis of acetylcholine produced end-plate current fluctuations at frog neuromuscular junction.

Authors:  C R Anderson; C F Stevens
Journal:  J Physiol       Date:  1973-12       Impact factor: 5.182

View more
  25 in total

1.  Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14.

Authors:  Bula J Bhattacharyya; Scott M Wilson; Hosung Jung; Richard J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-09       Impact factor: 4.249

2.  Fading responses in the evoked EMG after rocuronium in cats.

Authors:  H Shiraishi; H Suzuki; T Suzuki; N Katsumata; S Ogawa
Journal:  Can J Anaesth       Date:  1992-12       Impact factor: 5.063

3.  Neuromuscular blocking profile of the vecuronium analogue, Org-9487, in the rat isolated hemidiaphragm preparation.

Authors:  C Prior; L Tian; A I el Mallah; L Young; J M Ward
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

4.  Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium.

Authors:  T Searl; C Prior; I G Marshall
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

5.  Phenthonium, a quaternary derivative of (-)-hyoscyamine, enhances the spontaneous release of acetylcholine at rat motor nerve terminals.

Authors:  M L Fann; C Souccar; A J Lapa
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

6.  Nerve terminal currents induced by autoreception of acetylcholine release.

Authors:  W M Fu; H C Liou; Y H Chen
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

7.  Effects of (+)-tubocurarine on [3H]acetylcholine release from the rat phrenic nerve at different stimulation frequencies and train lengths.

Authors:  I Wessler; J Rasbach; B Scheuer; U Hillen; H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

8.  Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: link between positive (nicotinic)- and negative (muscarinic)-feedback modulation.

Authors:  E S Vizi; G T Somogyi
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

9.  Blockade by 2,2',2''-tripyridine of the nicotinic acetylcholine receptor channels in embryonic Xenopus muscle cells.

Authors:  K S Hsu; W M Fu; S Y Lin-Shiau
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

10.  Effects of diacylglycerol and phorbol ester on acetylcholine release and action at the neuromuscular junction in mice.

Authors:  R L Murphy; M E Smith
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.